Risk Mitigation in Topical Product Development

12:30 - 13:05

  • Understanding the differences in semi-solid and solid dosage form development
  • The risks associated with topical formulation development
  • The use of performance testing to optimise product safety, efficacy and quality

Rob Turner, Vice President of Business Development and Innovation, MedPharm